Literature DB >> 23432426

Intraoperative flow cytometry analysis of glioma tissue for rapid determination of tumor presence and its histopathological grade: clinical article.

Takahiro Shioyama1, Yoshihiro Muragaki, Takashi Maruyama, Takashi Komori, Hiroshi Iseki.   

Abstract

OBJECT: Intraoperative histopathological investigation plays an important role during surgery for gliomas. To facilitate the rapid characterization of resected tissue, an original technique of intraoperative flow cytometry (iFC) was established. The objective in this study was evaluation of this technique's efficacy for rapidly determining tumor presence in the surgical biopsy sample and WHO histopathological grade of the neoplasm.
METHODS: In total, 328 separate biopsy specimens obtained during the resection of 81 intracranial gliomas were analyzed with iFC. The evaluated malignancy index (MI) was defined as the ratio of the number of cells with greater than normal DNA content to the total number of cells. The duration of iFC in all cases was approximately 10 minutes. Each sample was additionally investigated histopathologically on frozen and permanent formalin-fixed paraffin-embedded tissue sections. The latter process was used as a "gold standard" control for evaluation of the diagnostic efficacy of iFC analysis.
RESULTS: The MI differed significantly between neoplastic and perilesional brain tissue (25.3% ± 22.0% vs 4.6% ± 2.6%, p < 0.01). Receiver operating characteristic curve analysis revealed a corresponding area under the curve value of 0.941. The optimal cutoff level of the MI for identification of tumor in the biopsy specimen was 6.8%, which provided 0.88 sensitivity, 0.88 specificity, 0.97 positive predictive value, 0.60 negative predictive value, and 0.88 diagnostic accuracy. Additionally, the MI showed a significant association with WHO histopathological grades of glioma (p < 0.01), but its values in Grade II, III, and IV tumors overlapped prominently and were on average 13.3% ± 11.0%, 35.0% ± 21.8%, and 46.6% ± 23.1%, respectively.
CONCLUSIONS: Results of this study demonstrate that iFC with the determination of the MI may be feasible for rapidly determining glioma presence in a surgical biopsy sample.

Entities:  

Mesh:

Year:  2013        PMID: 23432426     DOI: 10.3171/2013.1.JNS12681

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Mass spectrometry imaging as a tool for surgical decision-making.

Authors:  David Calligaris; Isaiah Norton; Daniel R Feldman; Jennifer L Ide; Ian F Dunn; Livia S Eberlin; R Graham Cooks; Ferenc A Jolesz; Alexandra J Golby; Sandro Santagata; Nathalie Y Agar
Journal:  J Mass Spectrom       Date:  2013-11       Impact factor: 1.982

2.  Prognostic significance of S-phase fractions in peritumoral invading zone analyzed by laser scanning cytometry in patients with high-grade glioma: A preliminary study.

Authors:  Syoichi Nakajima; Ken Morii; Hitoshi Takahashi; Yukihiko Fujii; Ryuya Yamanaka
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

Review 3.  Ambient ionization mass spectrometry imaging for disease diagnosis: Excitements and challenges.

Authors:  Shibdas Banerjee
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

Review 4.  Strategy of Surgical Resection for Glioma Based on Intraoperative Functional Mapping and Monitoring.

Authors:  Manabu Tamura; Yoshihiro Muragaki; Taiichi Saito; Takashi Maruyama; Masayuki Nitta; Shunsuke Tsuzuki; Hiroshi Iseki; Yoshikazu Okada
Journal:  Neurol Med Chir (Tokyo)       Date:  2015       Impact factor: 1.742

5.  Intraoperative quantification of meningioma cell proliferation potential using rapid flow cytometry reveals intratumoral heterogeneity.

Authors:  Soichi Oya; Shinsuke Yoshida; Tsukasa Tsuchiya; Naoaki Fujisawa; Akitake Mukasa; Hirofumi Nakatomi; Nobuhito Saito; Toru Matsui
Journal:  Cancer Med       Date:  2019-04-16       Impact factor: 4.452

6.  Quantitative Evaluation of Proliferative Potential Using Flow Cytometry Reveals Intratumoral Heterogeneity and Its Relevance to Tumor Characteristics in Vestibular Schwannomas.

Authors:  Soichi Oya; Shinsuke Yoshida; Shunya Hanakita; Mizuho Inoue
Journal:  Curr Oncol       Date:  2022-03-03       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.